Abstract
In this study, we evaluated the antitumor activity of a gene therapy complex in which the tumor-specific control of the expression of the effector suicide gene FCU1 was performed using a two-vector system based on the site-specific Cre-LoxP recombinase system. The complex of interest showed a high therapeutic potential in a mouse colon adenocarcinoma model.
MeSH terms
-
Adenocarcinoma* / genetics
-
Adenocarcinoma* / metabolism
-
Adenocarcinoma* / therapy
-
Animals
-
Cell Line, Tumor
-
Colonic Neoplasms* / genetics
-
Colonic Neoplasms* / metabolism
-
Colonic Neoplasms* / therapy
-
Genes, Transgenic, Suicide*
-
Genetic Vectors* / genetics
-
Genetic Vectors* / metabolism
-
Integrases* / genetics
-
Integrases* / metabolism
-
Mice, Inbred BALB C
-
Neoplasms, Experimental* / genetics
-
Neoplasms, Experimental* / metabolism
-
Neoplasms, Experimental* / therapy
Substances
-
Cre recombinase
-
Integrases